Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies

Trial number:
NCT03522155
Trial phase:
N/A
Study type:
Supportive interventions, Observational
Overall status:
Recruiting

Study start date

September, 2021

Scientific title

A Patient-Centered Approach to Integration of Life Expectancy Into Treatment Decision Making for Patients With Genitourinary Malignancy

Summary

Investigators will conduct a randomized trial to determine if providing patient-specific life expectancy estimates during treatment counseling via a targeted, patient-centered communication approach improves shared decision making and reduces rates of overtreatment of genitourinary malignancies.

Newly diagnosed clinical T1-2 prostate adenocarcinoma with Gleason scores of 7 or lessNewly diagnosed clinical T1a kidney cancer or renal masses < 4cm Newly diagnosed clinical T2 nonmetastatic urothelial carcinoma of the bladder

Under 18 years of ageSubjects with difficulty communicating or dementia Non-English speakers

Study design

Primary purpose: Health Services Research, Allocation: Randomized, Intervention model: Parallel Assignment, Intervention model description: This randomized controlled trial will involve two arms, Masking: None (Open Label),

Conditions

Prostate Cancer Stage I, Kidney Cancer Stage I, Bladder Cancer Stage II, Prostate Cancer Stage II

Other study ID numbers

Pro00052777

Choose trial site (1)